𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Acquired hypertrichosis lanuginosa. Report of two new cases and a review of the literature

✍ Scribed by Michael K. Samson; Thomas R. Buroker; Michael D. Henderson; Laurence H. Baker; Vainutis K. Vaitkevicius


Publisher
John Wiley and Sons
Year
1975
Tongue
English
Weight
253 KB
Volume
36
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Hypertrichosis lanuginosa is a pathologic state characterized by an excessive, new growth of fine, fetal hair. Two cases of hypertrichosis languinosa with malignancy (lymphoma and uterine cancer) are presented and added to the 9 in the literature. Lymphoma and uterine cancer are previously unreported as associated with hypertrichosis osis lanuginosa. Review of the 11 cases of hypertrichosis lanuginosa revealed the following characteristics: females were predominant; none was below the 4th decade; all had advanced neoplastic disease; all malignancies except one were of epithelial origin; and there were no demonstrable endocrine abnormalities. Despite an attempt to find etiologic factors in our patients and in the literature, none could be elicited.


πŸ“œ SIMILAR VOLUMES


Acquired hypertrichosis lanuginosa: Case
✍ FariΓ±a, M. Carmen; TarΓ­n, Nieves; Grilli, Renato; Soriano, M. Luisa; Sarasa, Jos πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 147 KB πŸ‘ 1 views

Acquired hypertrichosis lanuginosa is a rare cutaneous disorder usually associated with internal malignancy that consists of the development of abnormal hair growth of the lanugo type, often confined to the skin of the face and neck, although other areas also may be involved. We report on a 66-year-

Cyclophosphamide-induced cardiomyopathy.
✍ Barry A. Mills; Raymond W. Roberts πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 327 KB πŸ‘ 1 views

Fatal cardiomyopathy developed in two patients receiving cyclophosphamide in preparation for bone marrow transplantation. Both patients had normal EKGs prior to receiving cyclophosphamide in total doses of 168 mg/kg (case 1) and 144 mgkg (case 2) and subsequently developed loss of voltage and ST-T w